%L arxiv87717
%I Research Science and Innovation House
%J SYNAPSES: INSIGHTS ACROSS THE DISCIPLINES
%O Imported from Universal Publishings (OAI id oai:ojs.pkp.sfu.ca:article/18199)
%X Non-alcoholic fatty liver disease (NAFLD), recently rebranded as metabolic dysfunction-associated steatotic liver disease (MASLD), has emerged as one of the most pressing chronic liver conditions affecting the global population. Historically perceived as a disease of middle-aged and older adults with metabolic comorbidities, NAFLD is now increasingly diagnosed in adolescents and young adults aged 15–39 years. This demographic shift represents a significant public health concern, as early-onset hepatic steatosis provides a longer window for disease progression to non-alcoholic steatohepatitis (NASH), cirrhosis, and hepatocellular carcinoma.
%K Non-alcoholic fatty liver disease (NAFLD), metabolic dysfunction-associated steatotic liver disease (MASLD), young adults, adolescents, obesity, insulin resistance, epidemiology, liver fibrosis, public health, metabolic syndrome
%T RISING INCIDENCE OF FATTY LIVER DISEASE IN YOUNG ADULTS: EPIDEMIOLOGY, RISK FACTORS, AND PUBLIC HEALTH IMPLICATIONS
%A Dr. AMAN KHANDELWAL
%A Sahibole Mohammed
%A Zunaira Khan
%D 2026
%R oai:ojs.pkp.sfu.ca:article/18199